164 related articles for article (PubMed ID: 17120363)
21. Treating osteoporosis.
Smith G; Stassen L; Flint S
Ir Med J; 2009 Mar; 102(3):88; author reply 89. PubMed ID: 19489199
[No Abstract] [Full Text] [Related]
22. The tip of the iceberg.
Felsenfeld AL
J Calif Dent Assoc; 2005 Oct; 33(10):765-6. PubMed ID: 16350878
[No Abstract] [Full Text] [Related]
23. Slumbering time-bomb.
Dean F
Br Dent J; 2006 Sep; 201(5):249. PubMed ID: 16960582
[No Abstract] [Full Text] [Related]
24. A physician discusses the dental impact of oral bisphosphonates.
Roudebush CP
J Indiana Dent Assoc; 2006-2007 Winter; 85(4):4-5. PubMed ID: 17489111
[No Abstract] [Full Text] [Related]
25. Bisphosphonate medications--the good, the bad, and the ugly.
Bourgeois SL
Tex Dent J; 2009 Jul; 126(7):596-604. PubMed ID: 19753815
[No Abstract] [Full Text] [Related]
26. Bisphosphonate therapy and dental treatment.
Phillips G
J Mich Dent Assoc; 2009 Aug; 91(8):40, 42-5. PubMed ID: 19722373
[No Abstract] [Full Text] [Related]
27. Beyond bisphosphonates: thrombophilia, hypofibrinolysis, and jaw osteonecrosis.
McMahon RE; Bouquot JE; Glueck CJ; Griep J
J Oral Maxillofac Surg; 2006 Nov; 64(11):1704-5. PubMed ID: 17052602
[No Abstract] [Full Text] [Related]
28. The bisphosphonates struggle.
Johnston JW
J Mich Dent Assoc; 2006 Oct; 88(10):12. PubMed ID: 17078336
[No Abstract] [Full Text] [Related]
29. Bisphosphonates and their impact on patient treatment.
Kurtzman GM; Silverstein LH; Peden J
Pract Proced Aesthet Dent; 2006 Jun; 18(5):297-8. PubMed ID: 16903540
[No Abstract] [Full Text] [Related]
30. Is exposure of the jawbone mandatory for establishing the diagnosis of bisphosphonate-related osteonecrosis of the jaw?
Yarom N; Fedele S; Lazarovici TS; Elad S
J Oral Maxillofac Surg; 2010 Mar; 68(3):705. PubMed ID: 20171493
[No Abstract] [Full Text] [Related]
31. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
[No Abstract] [Full Text] [Related]
32. Osteonecrosis of the jaws: maxillofacial recommendations for bisphosphonate prescribers.
Landis BN; Dojcinovic I; Richter M; Hugentobler M
J Intern Med; 2007 Jan; 261(1):101-2. PubMed ID: 17222173
[No Abstract] [Full Text] [Related]
33. Bisphosphonates and oral health.
Ritter AV; Padilla R
J Esthet Restor Dent; 2008; 20(1):74-5. PubMed ID: 18237344
[No Abstract] [Full Text] [Related]
34. Bisphosphonate therapy and dental treatment.
Phillips G
J Indiana Dent Assoc; 2007-2008 Winter; 86(4):4-8. PubMed ID: 18363257
[No Abstract] [Full Text] [Related]
35. The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.
Kraj M; Pogłód R; Maj S; Owczarska K
Acta Pol Pharm; 2006; 63(5):450-2. PubMed ID: 17357613
[No Abstract] [Full Text] [Related]
36. Staging bisphosphonate-related osteonecrosis of the jaw should include early stages of disease.
McMahon RE; Bouquot JE; Glueck CJ; Griep JA; Adams WR; Spolnik KJ; Deardorf KA
J Oral Maxillofac Surg; 2007 Sep; 65(9):1899-900. PubMed ID: 17719423
[No Abstract] [Full Text] [Related]
37. Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients.
Wass JA
Clin Radiol; 2008 Jan; 63(1):78-9. PubMed ID: 18068793
[No Abstract] [Full Text] [Related]
38. Horizons: the 2009 table clinics.
Thumbigeremath V
Northwest Dent; 2009; 88(3):33-4, 87. PubMed ID: 19691205
[No Abstract] [Full Text] [Related]
39. Treating osteonecrosis.
Harrison Z
Br Dent J; 2006 Mar; 200(5):242-3. PubMed ID: 16528300
[No Abstract] [Full Text] [Related]
40. Bisphosphonate induced osteonecrosis of the jaws: unravelling uncertainty in disease causality.
Kelleher FC; McKenna M; Collins C; Brady G; Collins I; Crown J
Acta Oncol; 2007; 46(5):702-4. PubMed ID: 17562449
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
